These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1207452

  • 1. [The transformation fibrinogen-fibrin in umbilical cord blood. A contribution to fetal fibrinogen].
    Krause WH, Maus W.
    Med Welt; 1975 Nov 28; 26(48):2172-4. PubMed ID: 1207452
    [No Abstract] [Full Text] [Related]

  • 2. Coagulation studies of cord blood, with special reference to "fetal fibrinogen".
    von Felten A, Straub PW.
    Thromb Diath Haemorrh; 1969 Nov 15; 22(2):273-80. PubMed ID: 5393392
    [No Abstract] [Full Text] [Related]

  • 3. Detection of human fetal fibrinogen in umbilical cord plasma by parallel assays of immunoreactive and thrombin-clottable protein.
    Barr RD, Storbeck MM, Johnston MA, Horsewood P, Gauldie J.
    Ann Clin Res; 1983 Jun 15; 15(3):104-8. PubMed ID: 6416136
    [Abstract] [Full Text] [Related]

  • 4. Simulating fibrin clotting time.
    Marx G.
    Med Biol Eng Comput; 2006 Mar 15; 44(1-2):79-85. PubMed ID: 16929924
    [Abstract] [Full Text] [Related]

  • 5. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA, Siebenlist KR, Bergtrom G, Mosesson MW.
    Blood Coagul Fibrinolysis; 1993 Feb 15; 4(1):107-12. PubMed ID: 8457636
    [Abstract] [Full Text] [Related]

  • 6. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA, Fisher LM.
    Va Med Mon (1918); 1970 May 15; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract] [Full Text] [Related]

  • 7. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF, Pandi L.
    Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759
    [Abstract] [Full Text] [Related]

  • 8. [Blood coagulation studies in cord blood: fetal fibrinogen?].
    Gmür J, von Felten A, Straub W.
    Schweiz Med Wochenschr; 1970 Feb 14; 100(7):299-300. PubMed ID: 5461100
    [No Abstract] [Full Text] [Related]

  • 9. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
    Kudriashov BA, Molchanova LV, Kalishevskaia TM, Bazaz'ian GG, Pastorova VE, Sytina NP.
    Vopr Med Khim; 1969 Feb 14; 15(5):483-6. PubMed ID: 5368085
    [No Abstract] [Full Text] [Related]

  • 10. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW, Gibbs CS, Leung LL.
    Thromb Haemost; 2001 Dec 14; 86(6):1466-74. PubMed ID: 11776315
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen.
    Galanakis DK, Mosesson MW.
    Blood; 1976 Jul 14; 48(1):109-18. PubMed ID: 947399
    [Abstract] [Full Text] [Related]

  • 12. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI, Zubairov DM.
    Biokhimiia; 1988 Jul 14; 53(7):1203-13. PubMed ID: 3179367
    [Abstract] [Full Text] [Related]

  • 13. [Changes in fibrin formation in liver cirrhosis].
    Fernández J, Narvaiza MJ, Cuesta B, Páramo JA, López Fernández A, Febres R, Rocha E.
    Sangre (Barc); 1982 Jul 14; 27(4-B):705-26. PubMed ID: 7157141
    [No Abstract] [Full Text] [Related]

  • 14. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N.
    Thromb Haemost; 2001 Jan 14; 85(1):108-13. PubMed ID: 11204560
    [Abstract] [Full Text] [Related]

  • 15. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J, Soria C.
    Pathol Biol (Paris); 1974 Nov 14; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract] [Full Text] [Related]

  • 16. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N, Furihata K, Terasawa F, Nakagoshi R, Ueno I, Katsuyama T.
    Thromb Haemost; 1996 Jun 14; 75(6):887-91. PubMed ID: 8822581
    [Abstract] [Full Text] [Related]

  • 17. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ, Dray L, Ardaillou N.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):686-92. PubMed ID: 1108283
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H.
    Scand J Haematol; 1973 Dec 15; 10(4):291-7. PubMed ID: 4764611
    [No Abstract] [Full Text] [Related]

  • 19. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J, Boneu B, Mignon-Conte, Suc JM.
    Perspect Nephrol Hypertens; 1973 Dec 15; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract] [Full Text] [Related]

  • 20. Fibrin gel formation in a shear flow.
    Guy RD, Fogelson AL, Keener JP.
    Math Med Biol; 2007 Mar 15; 24(1):111-30. PubMed ID: 17018571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.